China clears Elekta's Gamma Knife Icon

The China Food and Drug Administration has cleared radiation oncology vendor...Read more on AuntMinnie.comRelated Reading: Elekta inks reseller agreement with Equicare Health Elekta teams up with IBM Watson Health Elekta points to new MR/RT research Elekta partners with Alliance for Cancer Care IBA, Elekta join forces on software development
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

James Salaz (left), of Montrose, Colorado, was diagnosed with a rare form of cancer in 2012 by Dr Choon-Kee Lee (right). After five years, Salaz learned he actually had blood vessel inflammation.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Publication date: Available online 14 November 2018Source: The American Journal of SurgeryAuthor(s): Erica Burkheimer, Leah Starks, Mariam Khan, Leon Oostendorp, Marianne K. Melnik, Mathew H. Chung, G. Paul WrightAbstractIntroductionObesity has been associated with negative oncologic outcomes in breast cancer.MethodsRetrospective review of patients with operable breast cancer at a single institution from 2009–2012. Patients with carcinoma in situ or metastatic disease were excluded. Variables included utilization of MRI, surgical treatment, perioperative, and long-term oncologic outcomes. Primary outcome was rate of ...
Source: The American Journal of Surgery - Category: Surgery Source Type: research
ConclusionsSeveral factors are associated with a non-complete mesorectal excision. Non-complete mesorectal grade is associated with decreased survival.
Source: The American Journal of Surgery - Category: Surgery Source Type: research
Publication date: Available online 14 November 2018Source: European Journal of RadiologyAuthor(s): Alireza Aminsharifi, Rajan T. Gupta, Efrat Tsivian, Sitharthan Sekar, Christina Sze, Thomas J. PolascikAbstractPurposeTo introduce and assess the efficacy of a reduced core targeted (RCT) biopsy template (image-targeted + laterally directed sextant biopsy) to detect clinically-significant cancer in patients with elevated PSA and a previous negative biopsy or on active surveillance. The performance and added value of either targeted alone vs random sextant vs combined biopsy template was appraised.MethodsData fro...
Source: European Journal of Radiology - Category: Radiology Source Type: research
AbstractPurposeWe aimed to validate the performance of the hepatitis B-based Hong Kong Liver Cancer (HKLC) staging system compared with the Barcelona Clinic Liver Cancer (BCLC) staging system in Chinese hepatocellular carcinoma (HCC) patients treated with conventional transarterial chemoembolization (TACE) as the initial treatment.Materials and MethodsThe study was approved by the Institutional Review Boards at all participating centers. This retrospective study included 715 patients with HCC who underwent TACE as the initial treatment between January 2008 and December 2016 at three Chinese institutions. All of the patient...
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
AbstractOne area which has emerged as an important factor for predicting molecular profile and treatment outcomes in metastatic colorectal cancer (mCRC) is primary tumor location. The importance of molecular characteristics of colorectal cancer has been firmly established in terms of prognosis and treatment algorithms for many years. Recent studies have also suggested that molecular profiles are important in locoregional therapies as well, with some data suggesting changes in treatment algorithms based on tumor location. Therefore, it is important for interventional radiologists to understand the basic molecular characteri...
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
Thursday is pancreatic awareness day.
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
In a move that will expand research and clinical trials, Roswell Park Comprehensive Cancer Center has announced a new academic agreement with one of Europe ’s oldest educational institutions. The collaboration with the Jagiellonian University (JU) in Kraków, Poland, will include exchanges of staff, students and scientific resources to advance the development of cancer therapies for patients worldwide. Effective immediately, the deal could see excha nge of students and faculty between the two centers…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news
CONCLUSIONS High-level expression of KIF22 was related to both tumor progression and adverse clinical outcome. For this reason, KIF22 may become a potential prognostic factor for PCa. PMID: 30427826 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
Authors: Shen T, Guo Q Abstract Proline-rich tyrosine kinase 2 (Pyk2) plays essential roles in tumorigenesis and tumor progression. Pyk2 serves as a non-receptor tyrosine kinase regulating tumor cell survival, proliferation, migration, invasion, metastasis, and chemo-resistance, and is associated with poor prognosis and shortened survival in various cancer types. Thus, Pyk2 has been traditionally regarded as an oncogene and potential therapeutic target for cancers. However, a few studies have also demonstrated that Pyk2 exerts tumor-suppressive effects in some cancers, and anti-cancer treatment of Pyk2 inhibitors m...
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Food and Drug Administration (FDA) | Radiology